LA JOLLA, CA--(Marketwire - December 10, 2007) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications, today announced that Dr. Juliet Singh, President and Chief Executive Officer, will present a company overview at the New York Society of Security Analysts ("NYSSA") 11th Annual Biotech & Specialty Pharma Industry Conference on Wednesday, December 12th at 2:05 p.m. Eastern Time. The conference will be held at NYSSA's headquarters located at 1177 Avenue of the Americas in New York City.
